Ascletis Pharma Times and Sales

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen
			Ausblick

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

Ausblick

Ascletis Pharma Times and Sales (STU)

Zeit	Kurs	Umsatz grafisch
Times and Sales Zur Zeit stehen keine Daten zur Verfügung
Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

19:15		3 Reasons to Avoid Beyond Meat Stock
19:03		Elon Musk Seeks Privacy In Custody Battle With Grimes, Legal Showdown Intensifies
19:00		Why Utilities Might Be the Best Buying Opportunity Right Now
19:00		Binance’s explosive growth led to compliance failures - CEO Richard Teng on $4.3B settlement
18:54		UN secretary-general lambasts COP28 presidency’s net zero charter
18:54		UN secretary-general lambasts COP28 presidency’s net zero charter
18:44		Kevin O'Leary Takes Swipe At FTX, Binance While Lauding Launch Of New Crypto Exchange: 'This Is The End Of A Long Period Of Crypto Cowboyness'
18:07		3 Top Gaming Stocks to Buy in December
18:01		Market Snapshot: ‘Soft landing’ hope drives a stellar stock-market rally. Why U.S. economy is still not out of the woods.
18:00		Freedom Forever Solar Review: Well-Established With Some Creative Solutions - CNET
18:00		Promis werben für Krypto: Deshalb ist für Anleger Vorsicht geboten
17:51		Snowflake Stock: Headed to $235?
17:18		Zehn Tipps, wie man sein Unternehmen verkauft
17:14		Evergrande creditors make last push to avert liquidation order
17:03		Ein Instrument, das mit Marktmythen aufräumt und Gewinne freilegt
17:00		Snag This All-in-One Microsoft Bundle for Just $50 Today Only at StackSocial - CNET
17:00		Crypto Biz: UAE’s regulatory structure draws crypto firms, Canaan’s revenue slumps, and more
17:00		3 Dates for Disney Stock Investors to Circle in December
16:40		British American Tobacco Stock: Buy, Sell, or Hold?
16:32		Apple Is Far Less Important to Berkshire Hathaway Than You Think
16:30		Tesla Dug Its Own Grave With the Cybertruck. Or Did It?
16:22		AES Sees Years of Growth Ahead as It Invests More in Clean Energy
16:10		These 3 Stocks Might Be Getting a Little Too Expensive
16:00		‘People want something that’s not on Amazon’: the rise of the UK craft fair
15:56		Here's Why Investors Don't Care That Amazon Just Sold 1 Billion Products
15:53		Best Stock to Buy: Pinduoduo (PDD) vs. JD.com
15:46		How To Collect Big Yields With Less Heartburn
15:45		Where Will Coca-Cola Stock Be in 1 Year?
15:38		Where Will 3M Be in 1 Year?
15:36		Neiman Marcus Turns Down Saks Fifth Avenue's $3 Billion Takeover Bid
15:30		After Soaring in 2023, Is Apple a Smart Stock to Buy in 2024?
15:06		3 Things Beyond Meat Will Need to Do in 2024 (if It Wants to Survive)
14:51		Why This Underappreciated Vanguard Fund Could Be Worth Buying Right Now
14:36		Here's the Latest on Amazon's Acquisition of iRobot at the End of 2023
14:30		Snowflake Just Impressed Investors: 2 Reasons to Buy the Stock, and 1 Reason to Avoid It
14:25		Better ETF to Buy: Vanguard Growth Fund vs. Invesco QQQ Trust
14:17		2 Little-Known Social Security Rules Everyone Needs to Know by the Time They Reach 62
14:15		These 2 Artificial Intelligence (AI) Stocks Could Zoom Past $4 Trillion in 2024, According to Wall Street
14:10		This Pet Stock Is in the Doghouse, but Right Now Could Be a Golden Buying Opportunity
14:05		Diese Traumvillen sind am World Architecture Festival nominiert
14:00		ORDI Shatters Records With New All-Time High In Bullish Surge
14:00		MediaTek's AI-Powered Chips Aim To Make Your Next Phone Very Personal - CNET
14:00		Retiring in 2024? Make Sure You Can Answer These 5 Questions First.
14:00		History Says the Nasdaq Could Soar in 2024 -- 5 Stocks You'll Wish You'd Bought if It Does
13:56		Is It Too Late to Buy Snowflake Stock?
13:40		Is Etsy a Buy Now?
13:35		IBM Teams Up With Amazon for Cloud Database Service
13:30		3 Green Flags for Alphabet’s Future
13:23		3 Tech Giants Reshaping the Future With Bold Moves
13:20		New AI News Just Dropped: What This Means for Nvidia Investors

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Ascletis Pharma Aktie VALOR 42822928 / ISIN KYG0520K1094

Ascletis Pharma Times and Sales (STU)

Times and Sales

Eintrag hinzufügen Eintrag bearbeiten

Analysen zu Ascletis Pharma Inc. Registered Shs Unitary 144A-Reg S

Weitere Meldungen